 Calmette-Guerin treatment superficial bladder cancer total patients bladder cancer bacillus Calmette-Guerin BCG Significant bladder tumor remissions patients patients carcinoma situ noncompliant carcinoma situ patients remission BCG additional patients superficial bladder cancer remission rates encouraging patients remission bladder tumor half dose BCG adequate weeks Maintenance therapy important clinical arms BCG therapy results remission rate